BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34764332)

  • 1. Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
    Rauca VF; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Mot AC; Rakosy-Tican E; Sesarman A; Banciu M
    Sci Rep; 2021 Nov; 11(1):22102. PubMed ID: 34764332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.
    Rauca VF; Licarete E; Luput L; Sesarman A; Patras L; Bulzu P; Rakosy-Tican E; Banciu M
    PLoS One; 2018; 13(8):e0202827. PubMed ID: 30138430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress.
    Alupei MC; Licarete E; Patras L; Banciu M
    Cancer Lett; 2015 Jan; 356(2 Pt B):946-52. PubMed ID: 25444912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment.
    Licarete E; Rauca VF; Luput L; Drotar D; Stejerean I; Patras L; Dume B; Toma VA; Porfire A; Gherman C; Sesarman A; Banciu M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
    Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
    Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors.
    Smolarczyk R; Cichoń T; Pilny E; Jarosz-Biej M; Poczkaj A; Kułach N; Szala S
    Sci Rep; 2018 May; 8(1):7355. PubMed ID: 29743548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
    Banciu M; Metselaar JM; Schiffelers RM; Storm G
    Neoplasia; 2008 Feb; 10(2):108-17. PubMed ID: 18283332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis.
    Negrea G; Rauca VF; Meszaros MS; Patras L; Luput L; Licarete E; Toma VA; Porfire A; Muntean D; Sesarman A; Banciu M
    Front Pharmacol; 2022; 13():870347. PubMed ID: 35450036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.
    Carminati L; Pinessi D; Borsotti P; Minoli L; Giavazzi R; D'Incalci M; Belotti D; Taraboletti G
    Carcinogenesis; 2019 Apr; 40(2):303-312. PubMed ID: 30544170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 11. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
    Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
    Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5-fluorouracil in vivo.
    Luput L; Sesarman A; Porfire A; Achim M; Muntean D; Casian T; Patras L; Rauca VF; Drotar DM; Stejerean I; Tomuta I; Vlase L; Dragos N; Toma VA; Licarete E; Banciu M
    Cancer Sci; 2020 Apr; 111(4):1344-1356. PubMed ID: 31960547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.
    Downey CM; Aghaei M; Schwendener RA; Jirik FR
    PLoS One; 2014; 9(6):e99988. PubMed ID: 24940883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
    Banciu M; Metselaar JM; Schiffelers RM; Storm G
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):101-10. PubMed ID: 18602825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly-l-Lysine inhibits VEGF and c-Myc mediated tumor-angiogenesis and induces apoptosis in 2D and 3D tumor microenvironment of both MDA-MB-231 and B16F10 induced mice model.
    Debnath S; Mukherjee A; Saha D; Dash J; Chatterjee TK
    Int J Biol Macromol; 2021 Jul; 183():528-548. PubMed ID: 33892042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Inhibitory Effect of Propylene Glycol Alginate Sodium Sulfate on Fibroblast Growth Factor 2-Mediated Angiogenesis and Invasion in Murine Melanoma B16-F10 Cells In Vitro.
    Ma H; Qiu P; Xu H; Xu X; Xin M; Chu Y; Guan H; Li C; Yang J
    Mar Drugs; 2019 Apr; 17(5):. PubMed ID: 31035725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis
    Sesarman A; Luput L; Rauca VF; Patras L; Licarete E; Meszaros MS; Dume BR; Negrea G; Toma VA; Muntean D; Porfire A; Banciu M
    J Liposome Res; 2024 Feb; ():1-12. PubMed ID: 38379249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
    Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
    Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
    Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
    Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of lipophilic statins depends on their combined actions on HIF-1α expression and redox status in B16.F10 melanoma cells.
    Alupei MC; Licarete E; Cristian FB; Banciu M
    Anticancer Drugs; 2014 Apr; 25(4):393-405. PubMed ID: 24441744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.